MIRA Pharmaceuticals, Inc.
MIRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18 | $19 | $95 | $95 |
| - Cash | $3 | $5 | $0 | $3 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $15 | $15 | $95 | $92 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$9 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$8 | -$12 | -$7 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.51 | -0.65 | -0.48 | -0.15 |
| % Growth | 21.5% | -35.4% | -220% | – |
| Operating Cash Flow | -$6 | -$5 | -$6 | -$1 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$5 | -$6 | -$1 |